|
|
|
|
Dear <<First Name>>
This month I’m looking forward to the 3rd Annual EMBL Australia PhD course at the Harry Perkins Institute, Perth, Western Australia.
This course has rapidly become the annual highlight of EMBL Australia activities, and I’m very proud of the unique opportunities it has created for young scientists and the way our students embrace this extraordinary learning experience. This year’s program is very exciting, with many well-known EMBL and affiliated Australian scientists introducing our new PhD students to a range of different scientific fields, and showing them how their research fits in to the greater global scientific picture. As with the EMBL PhD course in Europe upon which our course is based, these two weeks provide an opportunity for students at the same stages of their career to connect. It is a perfect time for them to network, cross-fertilise ideas, set up collaborations and forge relationships with more senior scientists that will travel with them for the rest of their careers.
In previous years, students have reported that after going to this course they feel more energised, focused and enthusiastic about their future science paths. I am sure this year will be no exception, and the participants will be rewarded by the extraordinary efforts of the organising committee and the remarkable contributions of the guest speakers.
This event inspires me in so many ways, but the lasting impression I’ve been left with is recognition of the high calibre of our next wave of future science leaders in Australia, and I’ve got a good feeling this particular cohort will not disappoint.
Best wishes,
Professor Nadia Rosenthal
Scientific Head, EMBL Australia
Please note that all replies to this newsletter go to info@emblaustralia.org. If you wish to email me directly, my address is nadia.rosenthal@emblaustralia.org.
|
|
(22 June-3 July, 2015)
The 3rd annual EMBL PhD course is a two-week residential programme that provides students with a valuable opportunity to learn and network across disciplines and research organisations Australia-wide. The programme provides students with an opportunity to engage with some of our most prominent Australian science leaders and fellow students in a more intimate setting.
The Harry Perkins Institute conducts innovative research that will lead to a better understanding of health and disease within the community. At the Perkins, research is conducted in a range of therapeutic areas but fouses predominantly on:
- Cardiovascular disease
- Cancer and
- Diabetes.
To read more about the Harry Perkins Institute please visit: www.perkins.org.au.
|
|
I am proud to announce that one of our outstanding Australian students, Morgan Oatley (former Monash University honours student) accepted an offer, to undertake a PhD at the prestigious EMBL, Mouse Biology Unit, Montorotondo in Italy.
Morgan will be part of the Lancrin Group. The Lancrin Group studies the haematopoietic systems and looks to develop strategies to improve methods for generating blood cells from stem cells.
From us all at EMBL Australia, I’d like to congratulate Morgan on her outstanding achievement and wish her every success in Italy and the future. Caio Morgan.
For more information on what the Lancrin group is doing visit: http://www.embl.it/research/unit/lancrin/.
|
|
The recruitment process at EMBL is not only competitive and challenging but is very different from how other Medical and Science Institutes recruit for their Group Leaders. The EMBL recruitment process usually occurs over several days, which includes candidates delivering a public talk, a panel interview, multiple one-on-one interviews and two-on-one interviews. Candidates take tours of the facilities and are invited to participate at many social engagements during the interview process. Another unique characteristic is that all the candidates go through the process at the same time, which makes the recruitment procedure very open and transparent. All candidates get to hear each other’s talks and meet each other at the social engagements.
What attracts many high calibre researchers to EMBL Australia as Group Leaders, is partly the prestige and partly, the unique funding model. The prestige comes with being part of the global EMBL network itself, which is known for its innovative life science research community, and the funding model, which is very attractive to researchers as it supports them for up to nine years. The research environment together with the funding allows Group Leaders to develop longer-term and potentially high-risk, high-reward projects with a wealth of influential and highly successful international connections and possibly collaborators that they may otherwise never have had the opportunity to link to.
Many candidates remark positively upon the unusual recruitment process whether they are successful or not in securing a coveted Group Leader position at EMBL, reflecting on the care and thoroughness of the design and how the numerous interactions made them feel more comfortable.
|
|
(10-11 October, 2015)
A call for abstracts has been made for the Australian Bioinformatics and Computational Biology Association (ABACBS) Conference in October. There is an exciting line-up of international and national speakers. Confirmed speakers include: Martha Bulyk (Harvard US), Chris Mason (Weill
 Cornell Medical College, US), Alistair Forest (Harry Perkins Institute for Medical Research, AU), Aaron Darling (UTS, AU), Jean Yang (University of Sydney, AU) and Melissa Davis (University of Melbourne, AU).
Closing date for submission is 14 of August 2015.
For more information: www.abacbs.org/conference. |
|
(22-24 October, 2015)
Proposals are now being called for students wishing to apply for a travel grant to attend the 17th EMBL PhD symposium in Heidelberg. The aim of this year’s symposium is to explore the importance of randomness and variability in biology. The symposium will be characterised by EMBL’s multidisciplinary hallmarks – bringing the ideas from various perspectives and disciplines, to inspire early career researchers to see biological systems from a new point of view.
EMBL Australia will be supporting ten Australian students to attend the PhD symposium in Germany. Grants are open to students from almost any field who are currently enrolled in a PhD program at an Australian University and have not yet submitted a thesis. Applications will be reviewed and ranked solely on the basis of qualification and scientific potential by the EMBL Australia Travel Grant selection committee.
The symposium grants opened on June 1 and close August 3 2015. Applications are online http://emblaustralia.fluidreview.com/.
Abstract submission deadline: 21 August; Early bird registration closes July 5 2015.
For more information about the symposium and symposium program please visit: www.phdsymposium.embl.org.
|
|
(25-27 November, 2015)
The annual EMBL Australia PhD symposium, organised by PhD students for young scientists embarking on careers in medical and biological sciences will be held at the Bio21 Institute in Melbourne in November. The theme for this year is “Completing the Pipeline: From Biology to Bioinformatics and Back Again”. Registration is now open.
The PhD symposium will be another fantastic opportunity for students from all disciplines associated with EMBL Australia to network with fellow students from all around Australia. It provides a perfect opportunity to exchange ideas with peers and senior scientists in a more casual setting.
Invited speakers this year are:
Prof Ian Chubb AC Chief Scientist of Australia
Prof Susan Clark Garvan Institute Sydney
Nobel Laureate Prof Peter Doherty AC Doherty Institute of Melbourne
Prof Elina Ikonen University of Helsinki
A/Prof Joanne Lind University of Western Sydney
Dr Geoff Macintyre University of Cambridge
A/Prof Ville-Petteri Mäkinen EMBL Australia/SAHMRI
Dr Lezanne Ooi University of Wollongong
Early bird discount closes 31st August. All students are welcome. Honours, Masters and PhD. http://eaps2015.eventbrite.com.au.
Twitter: @EMBLAuSymposium #EAPS15
Facebook: Aphdsymposium
|
|
EMBL Australia supports various internships and training courses. Currently, Merrimack Pharmaceuticals is offering a variety of internships. Merrimack is a biotechnology company based in Cambridge, Massachusetts which works as a community of researchers, clinicians and professionals seeking to make a difference in the lives of cancer patients.
Internships at Merrimack are unique and comprehensive. Internships are being offered in the following scientific areas:
- Computational Modelling
- Cell Biology
- Biochemistry
- Process Development
If you are interested in joining the Merrimack internship program contact:
Silvio Tiziani on silvio.tiziani@emblaustralia.org or otherwise write to interns@merrimackpharma.com.
Further information can be found: http://www.emblaustralia.org/About_us/news/Internships_at_Merrimack_Pharmaceuticals.
|
|
The Systems Biology Institute (SBI) Australia is seeking a Director, a self-motivated internationally recognised academic in systems biology. This is a new position leading the newly formed SBI Australia, the first international node of SBI Japan and an EMBL Australia initiative.
For all vacant positions see: http://www.emblaustralia.org/About_us/jobs.
|
|
About EMBL Australia
EMBL - the European Molecular Biology Laboratory - is Europe's flagship for the life sciences. The Australian government joined EMBL as an Associate Member in 2008.
EMBL Australia is an unincorporated joint venture between members of the Group of Eight universities and the CSIRO, supported by the Australian government.
Read more about EMBL Australia
|
|
|
|
|
|
|
|
